Logo for LaunchBio Program: Investor ConnectLogo for LaunchBio Program: Investor Connect

Bridging the gap between innovation and capital

Online

Frazier Life Sciences

Focus on Therapeutic Biotech Companies

Program

Frazier Life Sciences, a global biotherapeutics company, primarily invests in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Frazier Life Sciences manages over $3.9 billion in capital, including venture funds focusing on company creation and private companies and a public long-only fund focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by Frazier, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep expertise in biopharmaceuticals, primarily located in Palo Alto (headquarters), San Diego, Seattle, Boston, New York and London.

Event

LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Frazier Life Sciences.

 


Applications will be selected based on meeting the following criteria:

Geography:
Mostly North America, but also recently invested in Europe

Company type:
Focus on biotherapeutics exclusively, and prefer companies near IND or in early clinical stage

Areas of Interest:

  • Biologics
  • Cell therapies
  • CRISPR-based therapies
  • Gene therapies
  • Protein-based therapies
  • Regenerative Medicine
  • RNA-based therapeutics
  • Small molecule
  • Vaccines


Research areas of interest include, but are not limited to:

  • Open to all target organs/systems and a broad range of therapeutic areas, including cardiology, endocrinology, hematology, oncology, ophthalmology, pulmonology, rare diseases, and more.


Stage:
Companies seeking funding for Seed, Series A, Series B and beyond.

 


Qualifying start-ups can apply here today.

Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.